Sr. Advisor - GFD HSE at Eli Lilly and Company

Houston, Texas, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Bachelor’s degree in engineering / construction management / HSE Fields or equivalent project / construction experience
  • 10 years Lead Role for Contractor Safety in Large Projects (>$1B)

  • Technical expert for the LIFE /SIF Programs/Risks for Construction Safety (eg Rigging, Excavation, Fall Prevention, Electrical Safety, etc.)
  • Trained in RCA methodology
  • Have working knowledge in Environmental Programs applicable to the Construction Industry (NPDES/SWPP, SPCC and Hazardous Waste Management)
  • Demonstrated value for a disciplined, structured approach to project management that is based on compliance with Policies and Procedures

Responsibilities

  • Lead the management of GFD’s Contractor Safety Management Program (CSMP) and be a Subject Matter Expert (SME) for GFD HSE documents and standards adapting to Regulatory requirements and integrating local requirements in conjunction with industry and corporate standards
  • Lead HSE Project Field execution inspections against regulatory, corporate and GFD HSE standards
  • Be a technical expert for the LIFE Programs/Risks applicable to the projects assigned as HSE Lead as well as a global SME for multiple Construction Safety High Risk Program (eg Rigging, Excavation, Fall Prevention, Electrical Safety, etc.)
  • Develop analytics for GFD’s project specific, regional, and global safety performance for large scale projects across multiple locations. Must be able to complete detailed trend analysis for the assigned projects
  • Lead or support the investigation and Root Cause Analysis (RCA) of unplanned, adverse incidents
  • Manage and / or own relationship with leveraged Safety Advisor(s) or strategic partners
  • Develop GFD’s Safety processes for Hazard Recognition and Risk Assessment, Confined Space Entry (CSE), Hot Work Permit (HWP), Lock Out/Tag Out (LOTO), Safe To Operate Permit (STOP), etc
  • Develop GFD’s Contractor’s Fundamental Requirements which will consist of a “document” providing guidance to our projects workforces to ensure their understanding and alignment with our fundamentals of safe work practices
  • Work closely with Global HSE to ensure alignment with corporate priorities and standards
  • Apply technical skills at a network / global level by demonstrate high degree of influence and superior problem-solving skills

Skills

HSE Standards
Contractor Safety Management
Regulatory Compliance
Safety Inspections
Risk Management
Project Execution
Corporate Standards
CSMP

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI